The lipid-lowering effect of ezetimibe in pure vegetarians

Jacob J. Clarenbach, Michael Reber, Dieter Lütjohann, Klaus Von Bergmann, Thomas Sudhop

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Results of previous studies have shown that ezetimibe (10 mg/day) reduces LDL cholesterol in patients with mild hypercholesterolemia on a normal-cholesterol diet (dietary intake of 200-500 mg/day) by 16-22%. However, the LDL cholesterol-lowering effect of ezetimibe in subjects with an extremely low dietary cholesterol intake (vegetarians) has not been studied. We conducted a randomized, double-blind, placebo-controlled, two-phase crossover study in 18 healthy pure vegetarians to assess the effect of ezetimibe (10 mg/day) on plasma lipids, cholesterol absorption, and its synthesis. Treatment periods lasted 2 weeks each, with an intervening 2 week washout period. Fractional cholesterol absorption was determined using the continuous dual stable isotope feeding method. Mean dietary cholesterol intake in the pure vegetarians was extremely low and averaged 29.4 ± 16.8 and 31.4 ± 14.4 mg/day during the placebo and ezetimibe administration phases, respectively. Fractional cholesterol absorption during the placebo phase was 48.2 ± 8.2% and was decreased by 58% during ezetimibe treatment to 20.2 ± 6.2% (P < 0.001). This change in intestinal cholesterol absorption was followed by a significant reduction in LDL cholesterol of 17.3%. In individuals with extremely low dietary cholesterol intake, treatment with ezetimibe (10 mg/day) leads to a significant reduction of cholesterol absorption and a clinically relevant decrease of plasma LDL cholesterol, comparable to that of subjects with a normal dietary cholesterol intake. Thus, the lipid-lowering effect of ezetimibe is mediated mainly through a reduction of the absorption of endogenous (biliary) cholesterol.

Original languageEnglish (US)
Pages (from-to)2820-2824
Number of pages5
JournalJournal of Lipid Research
Volume47
Issue number12
DOIs
StatePublished - Dec 1 2006

Keywords

  • Campesterol
  • Cholesterol absorption
  • Cholesterol synthesis
  • Lathosterol
  • Sitosterol

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Fingerprint Dive into the research topics of 'The lipid-lowering effect of ezetimibe in pure vegetarians'. Together they form a unique fingerprint.

  • Cite this

    Clarenbach, J. J., Reber, M., Lütjohann, D., Von Bergmann, K., & Sudhop, T. (2006). The lipid-lowering effect of ezetimibe in pure vegetarians. Journal of Lipid Research, 47(12), 2820-2824. https://doi.org/10.1194/jlr.P600009-JLR200